Genesis IBRC India

Genesis IBRC India EBIT Margin

Delisted·Sep 16, 2026

The EBIT Margin (Operating Margin) of Genesis IBRC India (514336.BO) as of Nov 3, 2026 is 2.06 %. In the previous year, EBIT Margin (Operating Margin) was -46.20 % — a change of -104.46% (higher).

EBIT Margin

2.06 %

YoY

-104.46%

Last updated:

EBIT Margin (Operating Margin) of Genesis IBRC India is 2018 2.06 % . EBIT Margin (Operating Margin) of Genesis IBRC India was 2017 -46.20 % . It decreases by -104.46% higher compared to the previous year.

Genesis IBRC India's operating (EBIT) margin stands at 2.1%, up from -87.2% several years earlier.

The Genesis IBRC India EBIT Margin history

  • 3 Years

  • 10 Years

  • 25 Years

  • Max

EBIT Margin
Date
EBIT Margin
Jan 1, 2014
-87.20 INR
Jan 1, 2015
-46.20 INR
Jan 1, 2018
2.06 INR
The Genesis IBRC India EBIT Margin history
YEAREBIT MarginYoY
2.06 %-104.46%
-46.20 %-47.02%
-87.20 %—

Access this data via the Eulerpool API

100,000 free requests/mo · no credit card

Genesis IBRC India Stock analysis

What does Genesis IBRC India do? Genesis IBRC India Ltd. generates revenue through the manufacturing and sale of pro-biotic products for aquaculture and fisheries, including GENPRO-WAT, PRO-VIBSOL, AMMONO-GEN, GENLACT, GROWFAST-GEN, and GEN-POND CLEAN. The company provides formulation research and development services for agriculture, aquaculture, poultry, and veterinary bio formulations, offering need-based product design, land labs, and consultation services. Its primary customers are businesses in aquaculture, fisheries, agriculture, and veterinary sectors seeking specialized pro-biotic solutions and R&D support. The company's product portfolio targets water and soil pro-biotics, vibrio controllers, ammonia and nitrites reducers, gut and intestinal pro-biotics, single cell protein, and fast decomposers. These solutions are designed to address specific challenges in aquatic and agricultural environments, such as water quality management and animal health. The firm's R&D services cater to clients requiring tailored bio-formulation development and technical expertise for their operational needs. Genesis IBRC India is one of the most popular companies on Eulerpool.

Frequently Asked Questions about Genesis IBRC India stock

EBIT Margin (Operating Margin) of Genesis IBRC India is 2.06 % in 2018.

EBIT Margin (Operating Margin) of Genesis IBRC India changed from -46.20 % to 2.06 %, representing a -104.46% change. The value is higher than the previous year.

On Eulerpool you can find the complete historical development of EBIT Margin (Operating Margin) Genesis IBRC India since 2006 – with annual values, charts, and detailed analysis.

EBIT Margin measures operating profitability as a percentage of revenue. It shows how much profit a company makes from operations before interest and taxes.

A 'good' varies by industry and company stage. On Eulerpool, you can compare EBIT Margin (Operating Margin)'s Genesis IBRC India with sector peers and the industry average to assess whether it is attractive.

To evaluate EBIT Margin (Operating Margin)'s, it is essential to compare it with peers in the same industry and sector. On Eulerpool, you can find direct industry comparisons for EBIT Margin (Operating Margin).

Access this data via the Eulerpool API

100,000 free requests/mo · no credit card

Margins — Genesis IBRC India

All Key Metrics — Genesis IBRC India